SORBS2 has been reported to function as a tumor suppressor in hepatocellular carcinoma, gastric cancer, pancreatic cancer, clear cell renal cell carcinoma and ovarian cancer [45, 58–61]. Here, SORBS2 is linked to ovarian carcinoma.